Muna Abu Sin
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Clostridium difficile and Clostridium perfringens research 3
- Viral Infections and Vectors 3
- SARS-CoV-2 and COVID-19 Research 3
- Antimicrobial Resistance in Staphylococcus 3
-
- Antibiotic Use and Resistance 11
- Co-authors
- Tim Eckmanns (30 shared papers)Sebastian Haller (14 shared papers)Diamantis Plachouras (4 shared papers)Dominique L. Monnet (2 shared papers)C. Suetens (4 shared papers)Bettina Weiß (3 shared papers)Edward Velasco (3 shared papers)Hans-Peter Blank (3 shared papers)
In The Last Decade
Muna Abu Sin
39 papers receiving 1.3k citations
Muna Abu Sin's Hit Papers
Peers
Comparison fields: 5 of 107
- Applied Microbiology and Biotechnology 140
- Molecular Medicine 204
- Infectious Diseases 463
- Critical Care and Intensive Care Medicine 110
- Clinical Biochemistry 83
Countries citing papers authored by Muna Abu Sin
This map shows the geographic impact of Muna Abu Sin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muna Abu Sin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muna Abu Sin more than expected).
Fields of papers citing papers by Muna Abu Sin
This network shows the impact of papers produced by Muna Abu Sin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muna Abu Sin. The network helps show where Muna Abu Sin may publish in the future.
Co-authors
The 25 scholars most cited alongside Muna Abu Sin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study Hit paper breakdown → | 2016 | 426 |
| 2 | 2020 | 157 | |
| 3 | 2016 | 98 | |
| 4 | 2018 | 63 | |
| 5 | 2018 | 61 | |
| 6 | 2018 | 56 | |
| 7 | 2015 | 50 | |
| 8 | 2007 | 40 | |
| 9 | 2017 | 39 | |
| 10 | 2009 | 38 | |
| 11 | 2018 | 33 | |
| 12 | 2007 | 33 | |
| 13 | 2005 | 28 | |
| 14 | 2019 | 28 | |
| 15 | 2016 | 27 | |
| 16 | 2012 | 26 | |
| 17 | 2018 | 23 | |
| 18 | 2014 | 19 | |
| 19 | 2015 | 18 | |
| 20 | 2012 | 16 |
About Muna Abu Sin
Muna Abu Sin is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Epidemiology, General Health Professions and Molecular Medicine, having authored 42 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (11 papers), Antibiotic Resistance in Bacteria (6 papers), Bacterial Identification and Susceptibility Testing (5 papers), Pneumonia and Respiratory Infections (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Viral Infections and Vectors (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (140 citations), Molecular Medicine (204 citations), Infectious Diseases (463 citations), Critical Care and Intensive Care Medicine (110 citations) and Clinical Biochemistry (83 citations). Muna Abu Sin has collaborated with scholars based in Germany, Sweden and Belgium. Frequent co-authors include Tim Eckmanns, Sebastian Haller, Diamantis Plachouras, Dominique L. Monnet, C. Suetens, Bettina Weiß, Edward Velasco, Hans-Peter Blank, Alessandro Cassini and Thomas Harder. Their work appears in journals such as Eurosurveillance, Antimicrobial Resistance and Infection Control, PLoS ONE, BMJ Open and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.